SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-004944
Filing Date
2017-05-04
Accepted
2017-05-04 16:26:39
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q MARCH 31, 2017 trevenaq12017.htm 10-Q 673092
2 EXHIBIT 31.1 trvnq12017-311.htm EX-31.1 15218
3 EXHIBIT 31.2 trvnq12017-312.htm EX-31.2 15212
4 EXHIBIT 32.1 trvnq12017-321.htm EX-32.1 9218
5 EXHIBIT 32.2 trvnq12017-322.htm EX-32.2 8865
  Complete submission text file 0001628280-17-004944.txt   4254161

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT trvn-20170331.xml EX-101.INS 889131
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trvn-20170331.xsd EX-101.SCH 29494
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trvn-20170331_cal.xml EX-101.CAL 52925
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trvn-20170331_def.xml EX-101.DEF 168711
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trvn-20170331_lab.xml EX-101.LAB 466315
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trvn-20170331_pre.xml EX-101.PRE 281109
Mailing Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406 610-354-8840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 17814340
SIC: 2834 Pharmaceutical Preparations